Novartis to Highlight Long-Term Data, Innovative Pipeline for Patients With

Novartis to highlight long-term data, innovative pipeline for patients with
TASIGNA® (nilotinib) is approved for the treatment of adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase. … use of strong CYP3A4 inhibitors or anti-arrhythmic drugs (including, but …
Read more on MarketWatch


New high causes users to rot from the inside out
"You can't take this drug without actually poisoning yourself." There are methods to treat opiate addiction, including taking other prescription opiates like methadone and suboxone. But opiate addiction is a chronic problem that comes with an extremely …
Read more on Sunday World

Comments are closed.